Half Year 2025 Bubs Australia Ltd Earnings Call Transcript
Key Points
- BUBS Australia Ltd (BUBSF) achieved a positive net profit after tax of $3.6 million, marking an $11.2 million improvement from the prior period.
- The company reported a positive EBITDA of $0.5 million, a significant improvement from a loss of $6.2 million in the previous period.
- Revenue increased by 23% to $48 million, with strong growth across all regions, particularly in the USA.
- Gross profit margins improved to 50%, driven by higher-margin pack formats, better inventory management, and favorable foreign exchange rates.
- BUBS Australia Ltd (BUBSF) holds a 10% share of the premium/natural better-for-you segment in the US infant milk formula market, with significant growth potential.
- Consumer sentiment in the US market is weakening, which could impact future revenue growth.
- The rollout of new pack formats impacted sales in the first half, although old formats have now been sold out.
- Amazon temporarily suppressed some BUBS products due to compliance issues, affecting sales, although this has been resolved.
- The company is behind its original timeline for FDA approval, although it remains on track for October 2025.
- There is a potential risk of tariffs being imposed on Australian goods in the US, which could affect pricing and demand.
Good morning, everyone, and welcome to Bubs half one FY25 results briefing. My name is Reg Weine, and I am the CEO and Managing Director of Bubs. And joining me on the call today is our new Chief Financial Officer, Naomi Verloop; and our General Counsel and Company Secretary, Peter Cope.
Before we get into the results briefing, I would like to draw your attention to our disclaimer on page 2 of the presentation and now on the screen, the agenda and content for today's presentation. We'll firstly cover the half one FY25 results and highlights. I'll then discuss Bubs' strategy and the significant and sustained progress we are now making on each one of our five strategic pillars and our plan to responsibly manage capital and maximize shareholder value. I'll then provide an update on our outlook and path to sustained profitability, and then I'll briefly touch on what I consider to be Bubs' investment highlights and the ingredients that make us such a strong investment proposition.
Looking at our half one
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

